Your browser doesn't support javascript.
loading
Granulocytes-Rich Thrombi in Cerebral Large Vessel Occlusion Are Associated with Increased Stiffness and Poorer Revascularization Outcomes.
Juega, Jesús; Li, Jiahui; Palacio-Garcia, Carlos; Rodriguez, Maite; Tiberi, Riccardo; Piñana, Carlos; Rodriguez-Luna, David; Requena, Manuel; García-Tornel, Álvaro; Rodriguez-Villatoro, Noelia; Rubiera, Marta; Muchada, Marian; Olivé-Gadea, Marta; Rizzo, Federica; Hernandez, David; Dios-Lascuevas, Marta; Hernandez-Perez, Maria; Dorado, Laura; Quesada, Helena; Cardona, Pere; De La Torre, Carolina; Gallur, Laura; Camacho, Jessica; Ramon-Y-Cajal, Santiago; Tomasello, Alejandro; Ribó, Marc; Molina, Carlos A; Pagola, Jorge.
Afiliação
  • Juega J; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Li J; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Palacio-Garcia C; Hematology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Rodriguez M; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Tiberi R; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Piñana C; Department of Neuroradiology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Rodriguez-Luna D; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Requena M; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • García-Tornel Á; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Rodriguez-Villatoro N; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Rubiera M; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Muchada M; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Olivé-Gadea M; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Rizzo F; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Hernandez D; Department of Neuroradiology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Dios-Lascuevas M; Department of Neuroradiology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Hernandez-Perez M; Department of Neurology, Germans Trias I Pujol University Hospital, Badalona, Spain.
  • Dorado L; Department of Neurology, Germans Trias I Pujol University Hospital, Badalona, Spain.
  • Quesada H; Department of Neurology, Bellvitge University Hospital, Hospitalet de Llobregat, Spain.
  • Cardona P; Department of Neurology, Bellvitge University Hospital, Hospitalet de Llobregat, Spain.
  • De La Torre C; Proteomics Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
  • Gallur L; Hematology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Camacho J; Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Ramon-Y-Cajal S; Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Tomasello A; Department of Neuroradiology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Ribó M; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain. marcriboj@hotmail.com.
  • Molina CA; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
  • Pagola J; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute. Universitat Autonoma de Barcelona, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain.
Neurotherapeutics ; 20(4): 1167-1176, 2023 07.
Article em En | MEDLINE | ID: mdl-37212981
We aim to identify a profile of intracranial thrombus resistant to recanalization by mechanical thrombectomy (MT) in acute stroke treatment. The first extracted clot of each MT was analyzed by flow cytometry obtaining the composition of the main leukocyte populations: granulocytes, monocytes, and lymphocytes. Demographics, reperfusion treatment, and grade of recanalization were registered. MT failure (MTF) was defined as final thrombolysis in cerebral infarction score IIa or lower and/or need of permanent intracranial stenting as a rescue therapy. To explore the relationship between stiffness of intracranial clots and cellular composition, unconfined compression tests were performed in other cohorts of cases. Thrombi obtained in 225 patients were analyzed. MTF were observed in 30 cases (13%). MTF was associated with atherosclerosis etiology (33.3% vs. 15.9%; p = 0.021) and higher number of passes (3 vs. 2; p < 0.001). Clot analysis of MTF showed higher percentage of granulocytes [82.46 vs. 68.90% p < 0.001] and lower percentage of monocytes [9.18% vs.17.34%, p < 0.001] in comparison to successful MT cases. The proportion of clot granulocytes (aOR 1.07; 95% CI 1.01-1.14) remained an independent marker of MTF. Among thirty-eight clots mechanically tested, there was a positive correlation between granulocyte proportion and thrombi stiffness (Pearson's r = 0.35, p = 0.032), with a median clot stiffness of 30.2 (IQR, 18.9-42.7) kPa. Granulocytes-rich thrombi are harder to capture by mechanical thrombectomy due to increased stiffness, so a proportion of intracranial granulocytes might be useful to guide personalized endovascular procedures in acute stroke treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Transtornos Cerebrovasculares / Acidente Vascular Cerebral Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neurotherapeutics Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Transtornos Cerebrovasculares / Acidente Vascular Cerebral Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neurotherapeutics Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha